Integrated Biopharma, Inc.
INBP
$0.31
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 1.63% | 10.57% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.63% | 10.57% | |||
| Cost of Revenue | 2.50% | 8.33% | |||
| Gross Profit | -5.29% | 32.45% | |||
| SG&A Expenses | 8.37% | -16.20% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.86% | 6.41% | |||
| Operating Income | -20.30% | 265.84% | |||
| Income Before Tax | -23.52% | 320.54% | |||
| Income Tax Expenses | 362.87% | 142.03% | |||
| Earnings from Continuing Operations | -129.13% | 426.72% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -129.13% | 426.72% | |||
| EBIT | -20.30% | 265.84% | |||
| EBITDA | -19.02% | 185.96% | |||
| EPS Basic | -128.71% | 431.58% | |||
| Normalized Basic EPS | -19.61% | 247.73% | |||
| EPS Diluted | -129.00% | 440.54% | |||
| Normalized Diluted EPS | -16.89% | 244.19% | |||
| Average Basic Shares Outstanding | 1.02% | 0.42% | |||
| Average Diluted Shares Outstanding | -2.87% | 0.68% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||